-Dovetail increases global footprint with seven new distributors – SANTA CRUZ, Calif. — Dovetail Genomics™ LLC, which offers genomic products and services to address unmet needs in both human and non-human markets, expanded its growing international distribution network by signing additional partnerships in India, Australia, New Zealand, Taiwan, China, Thailand and Vietnam. Dovetails tools are used to generate accurate chromosome scale genome assemblies, identify large […]
Stratedigm is reinventing the way you design your automation experiments. With CellCapTure’s optional patent pending Visual Protocol Designer (VPD), users can easily create complex tasks and protocols to fully automate their experiments by utilizing a visual, drag-and-drop system. By utilizing “action blocks” for mixing, incubating, recording, and pipetting from well to well, users can now create novel […]
SAN ANTONIO, TX and HAYWARD, CA – Paragon Genomics, Inc., a leader in amplicon-based target enrichment and library preparation solutions for next-generation sequencing (NGS) assays today announced a partnership with SOPHiA GENETICS designed to accelerate the global adoption of Data-Driven Medicine worldwide. Under the terms of the agreement, Paragon Genomics’ CleanPlex® NGStarget enrichment technologies will be […]
SAN DIEGOT Allele Biotechnology & Pharmaceuticals Inc. has received issuance notices from the U.S. Patent and Trademark Office for its first batch of patents covering the derivation of induced pluripotent stem cells (iPSCs). Allele’s proprietary technology uses only messenger RNA (mRNA) to reprogram human or other primate cells, avoiding many operational complications that other methods […]
Agilent OnePGT solution empowers fertility specialists to attain comprehensive insights to improve the ranking of in vitro fertilized (IVF) embryos SANTA CLARA, Calif. Agilent Technologies Inc. (NYSE: A) today announced the introduction of Agilent OnePGT, a genome-wide, next-generation sequencing (NGS) solution for preimplantation genetic testing (PGT). OnePGT allows parallel detection of multiple monogenic disorders (PGT-M), […]
COLOGNE, Germany & LEIDEN, Netherlands & CAMBRIDGE, England–Ncardia, a leader in human iPSC-based solutions for drug safety and efficacy screening, and Horizon Discovery Group plc (LSE:HZD) (Horizon), a global leader in gene editing and gene modulation technologies, announced a partnership to provide custom genetically modified and differentiated human iPSC-derived cells (hiPSC) for drug discovery researchers. […]
AMSBIO has expanded its range of high quality FFPE cancer cell line controls for immunohistochemistry (IHC), in situ hybridization (ISH) and Next Generation Sequencing (NGS) applications. Variations in FFPE tissue sample quality and experimental setup can lead to misleading results without reliable controls. Traditional cell or tissue-based control specimens often present intra specimen variation, lot-to-lot variations […]
Illumina Launches TruSight Oncology 500 to Power Comprehensive, Accurate, Pan-Cancer Tumor Profiling
SAN DIEGO— Illumina, Inc. (NASDAQ: ILMN) today announces the launch of TruSightTM Oncology 500 (TSO 500), a comprehensive pan-cancer assay designed to identify known and emerging tumor biomarkers. TruSight Oncology 500 utilizes both DNA and RNA from subject tumor samples to identify key somatic variants underlying tumor progression, such as small DNA variants, fusions, and splice variants. Importantly, […]
SAN FRANCISCO–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA, today announced that it has priced its initial public offering of 5,000,000 shares of its common stock at a price to the public of $14.00 per share, before underwriting discounts and commissions. All of the shares of common stock are […]
SALT LAKE CITY–Privately held XCR Diagnostics Inc. and Luminex Corporation (Nasdaq:LMNX) have entered into a non-exclusive, worldwide license agreement for XCR’s proprietary Xtreme Chain Reaction nucleic acid amplification technology. The XCR technology enables extremely rapid thermal cycling protocols to achieve dramatically reduced assay turnaround times compared to traditional polymerase chain reaction. Financial terms were not disclosed. “XCR […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
